LIMN US Equity
Liminatus Pharma, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1971387 · FY ends Dec 31$5.16
-0.47 (-8.35%)
USD · as of 2026-08-21 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 4.2M |
| % of shares out | 6.3% |
| Days to cover | 1.0 |
| Δ vs 2026-07-15 | +76.1% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 4,234,144 | +76.1% | 52,873,116 | 1.0 |
| 2026-07-15 | 2,404,454 | +106.0% | 75,297,149 | 1.0 |
| 2026-06-30 | 1,167,107 | +28.2% | 7,729,303 | 1.0 |
| 2026-06-15 | 910,412 | -25.9% | 4,005,524 | 1.0 |
| 2026-05-29 | 1,228,229 | +118.4% | 44,575,019 | 1.0 |
| 2026-05-15 | 562,363 | -48.1% | 643,391 | 1.0 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
